Article Sidebar

Submitted
February 11, 2021
Accepted
August 26, 2021
Published
August 31, 2021
Download
PDF
Statistic
Read Counter : 432 Download : 2206

Main Article Content

Abstract

Background: Benign prostatic hyperplasia (BPH) is a pathologic process that cause of lower urinary tract symptoms (LUTS) in aging men. Transurethral resection of the prostate (TURP) is still the current gold standard of BPH treatment. International Prostate Symptoms Score (IPSS) and the quality of life (QoL) index are used for assessing the TURP results.
Objective: This study would like to show the benefits outcome of TURP in patients with BPH evaluated with IPSS score and QoL index in Medan regional hospital.
Methods: This research is a retrospective study of BPH patients that is treated with TURP at Universitas Sumatera Utara Hospital from September 2019 – August 2020. Patients will be divided into 2 groups, group 1 with patients who have a prostate size <80 grams and the second group with a prostate size> 80 grams. All patients who were included in this study were assessed for their complaints using the IPSS and QoL index before and after taking an operation. Statistical analysis was performed using independent t test and Mann Whitney test. The data were significant if the p value < 0.05.
Results: There are 60 patients enrolled in this study that treated with TURP. The mean age of patients in the group 1 was 69.57 ± 7.698 years and 69.84 ± 5.893 years in the group 2. There is no significant difference between group 1 and group 2 in postoperative IPSS and QoL results (p >0.05).
Conclusion: TURP procedure is preferable option of BPH for patients in any prostate size.

Keywords

Benign prostatic hyperplasia Transurethral resection of the prostate IPSS Quality of life LUTS

Article Details

Author Biography

Richman Patandung, Departement of Urology, Faculty of Medicine, Universitas Sumatera Utara, Haji Adam Malik Hospital

Departement of Urology, Cipto Mangunkusumo Hospital,
How to Cite
Patandung, R., & Warli, S. M. (2021). Outcome benefits to transurethral resection of the prostate in patients with benign prostatic hyperplasia at Medan regional hospital. JKKI : Jurnal Kedokteran Dan Kesehatan Indonesia, 12(2), 137–143. https://doi.org/10.20885/JKKI.Vol12.Iss2.art6
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Welliver C, Helo S, McVary KT. Technique considerations and complication management in transurethral resection of the prostate and photoselective vaporization of the prostate. Translational andrology and urology. 2017; 6: 695-703.
  2. Palaniappan S, Kuo TL, Cheng CW, Foo KT. Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate. Singapore Medical Journal. 2016; 57(12): 676-80.
  3. Madersbacher S, Sampson N, Culig Z. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: A mini-review. Gerontology. 2019; 65(5): 458-64.
  4. Skinder D, Zacharia I, Studin J, Covino J. Benign prostatic hyperplasia: A clinical review. Journal of the American Academy of Physician Assistants. 2016; 29(8): 19-23.
  5. Foo KT. Pathophysiology of clinical benign prostatic hyperplasia. Asian Journal of Urology. 2017; 4: 152-157.
  6. Foo KT. What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)? World Journal of Urology. 2019; 37: 1293-1296.
  7. Ng M, Baradhi KM. Benign prostatic hyperplasia. BTI - StatPearls (2020).
  8. Sarier M, Duman I, Demir M, Yüksel Y, Emek M, Kukul E. The outcomes of transurethral incision/resection of the prostate (TUIP/TURP) performed early after renal transplantation. Turkish Journal of Urology. 2018; 44: 172-177.
  9. Kim EH, Larson JA, Andriole GL. Management of benign prostatic hyperplasia. Annual Review of Medicine. 2016; 67: 137-151.
  10. Liao CH, Chung SD, Kuo HC. Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms. International Journal of Clinical Practice. 2011;65(5):552-8.
  11. Macey MR, Raynor MC. Medical and surgical treatment modalities for lower urinary tract symptoms in the male patient secondary to benign prostatic hyperplasia: A Review (2016). Seminars in Interventional Radiology. 2016; 33(3): 217-223.
  12. Nunes RLV, Antunes AA, Constantin DS. Contemporary surgical treatment of benign prostatic hyperplasia. Revista da Associacao Medica Brasileira. 2017; 63(8): 711-716.
  13. Yucel M, Aras B, Yalcinkaya S, Hatipoglu NK, Aras E. Conventional monopolar transurethral resection of prostate in patients with large prostate (=80 grams). Central European Journal of Urology. 2013; 66, 303-308.
  14. Huang LK, Chang YH, Shao IH, Lee TL, Hsieh ML. Clinical outcome of immediate transurethral surgery for benign prostate obstruction patients with acute urinary retention: More radical resection resulted in better voiding function. Journal of clinical medicine. 2019; 8: 1278.
  15. Teo JS, Lee YM, Ho HSS. An update on transurethral surgery for benign prostatic obstruction. Asian Journal of Urology. 2017; 4: 195-198.
  16. Joniau SG, Van Baelen AA, Hsu CY, Van Poppel HP. Complications and functional results of surgery for locally advanced prostate cancer. Advances in urology. 2012; 706309.
  17. Bortnick E, Brown C, Simma-Chiang V, Kaplan SA. Modern best practice in the management of benign prostatic hyperplasia in the elderly. Therapeutic Advances in Urology. 2020; 12: 1756287220929486.
  18. Joshi HN, De Jong IJ, Karmacharya RM, Shrestha B, Shrestha R. Outcomes of transurethral resection of the prostate in benign prostatic hyperplasia comparing prostate size of more than 80 grams to prostate size less than 80 grams. Kathmandu University medical Journal. 2014; 12(47) 163-7.